These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21124328)

  • 1. The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study.
    Yamamoto K; Ozaki H; Takayasu K; Akehi N; Fukui S; Sakai A; Kodama M; Shimonagata T; Kobayashi K; Ota M; Horiguchi Y; Ebisuno S; Katsube Y; Yamazaki T; Ohtsu H; Hori M
    Hypertens Res; 2011 Mar; 34(3):325-30. PubMed ID: 21124328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension (J-ELAN): rationale and design.
    J-ELAN Investigators
    Circ J; 2006 Jan; 70(1):124-8. PubMed ID: 16377936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [J-ELAN study (effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension)].
    Yamamoto K; Hori M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():513-5. PubMed ID: 17511101
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
    Takami T; Shigematsu M
    Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy.
    Ohta Y; Kawano Y; Iwashima Y; Hayashi S; Yoshihara F; Matayoshi T; Takiuchi S; Kamide K; Nakamura S; Horio T
    Clin Exp Hypertens; 2013; 35(4):279-84. PubMed ID: 23530977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
    Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
    Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
    Phillips RA; Kloner RA; Grimm RH; Weinberger M
    J Clin Hypertens (Greenwich); 2003; 5(1):17-23. PubMed ID: 12556649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
    Fogari R; Mugellini A; Destro M; Corradi L; Lazzari P; Zoppi A; Preti P; Derosa G
    Diabet Med; 2012 Jan; 29(1):24-31. PubMed ID: 21781149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension: accurate evaluation using a newly developed color-coded tissue doppler imaging technique.
    Tanaka H; Oki T; Tabata T; Yamada H; Harada K; Kimura E; Oishi Y; Ishimoto T; Ito S
    J Card Fail; 2004 Oct; 10(5):412-20. PubMed ID: 15470652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N; Ishii K; Kihara H; Iwakura K; Watanabe H; Yoshikawa J; Ito H;
    Circ J; 2016; 80(2):426-34. PubMed ID: 26725762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine.
    Pareek A; Chandurkar NB; Sharma R; Tiwari D; Gupta BS
    Clin Drug Investig; 2010; 30(2):123-31. PubMed ID: 20067330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.
    Martina B; Dieterle T; Weinbacher M; Battegay E
    Cardiology; 1999; 92(2):110-4. PubMed ID: 10702653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).
    Ikeda H; Minamikawa J; Nakamura Y; Honjo S; Hamamoto Y; Wada Y; Nabe K; Koshiyama H
    Diabetes Res Clin Pract; 2009 Jan; 83(1):50-3. PubMed ID: 19070383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW; Lacourcière Y; Barnes CC
    CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.